SureTrader
Home > Boards > US Listed > Biotechs >

Nabriva Therapeutics AG (NBRV)

NBRV RSS Feed 		Add NBRV Price Alert      Hide Sticky   Hide Intro
Moderator: faxedreceipts
Search This Board: 
Last Post: 4/13/2018 9:10:05 AM - Followers: 10 - Board type: Free - Posts Today: 0

Nabriva Therapeutics AG Leberstrasse 20 Vienna, 1110 Austria Phone: 43 1 740 93 0 Fax: 43 1 740 93 1900 Website: http://www.nabriva.com Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007. Nabriva Therapeutics AG was incorporated in 2005 and is headquartered in Vienna, Austria.
SureTrader
NBRV
Current Price
Volume:
Bid Ask Day's Range
NBRV Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
NBRV News: Current Report Filing (8-k) 04/20/2018 04:09:37 PM
NBRV News: Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology a... 04/20/2018 10:17:00 AM
NBRV News: Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bact... 04/13/2018 07:00:00 AM
NBRV News: Schedule 13g 04/10/2018 11:04:11 AM
NBRV News: Securities Registration Statement (simplified Form) (s-3/a) 04/09/2018 04:14:06 PM
News News Alert: Current Report Filing (8-k) 04/20/2018 04:09:37 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#32   Nabriva Therapeutics to Present Data at ECCMID Demonstrating realfast95 04/13/18 09:10:05 AM
#31   WOW! Nice 13.7% stake in NBRV by Wellington! bUrRpPPP! 04/11/18 05:47:54 AM
#30   well this amateur likes all the different tables realfast95 04/10/18 04:09:19 PM
#29   Use SEC.GOV...Nasdaq.com is for amateurs. faxedreceipts 04/10/18 03:58:18 PM
#28   very odd, the NBRV SEC filings stop in realfast95 04/10/18 03:49:08 PM
#27   Wellington Management Group owns 14 percent as of faxedreceipts 04/10/18 02:54:28 PM
#26   http://www.wbtv.com/story/37883802/antibiotic-resistant-nightmare-bacteria-a-gro faxedreceipts 04/05/18 09:39:49 AM
#25   True especially if the sellers are ambushed by faxedreceipts 04/03/18 10:56:16 AM
#24   If phase 3 results are good? sales randychub 04/03/18 10:34:22 AM
#23   The question is who the heck is selling faxedreceipts 04/03/18 10:25:29 AM
#22   I agree. We should know soon. randychub 04/03/18 10:24:01 AM
#21   If the data is good for NBRV, oral faxedreceipts 04/03/18 08:57:56 AM
#20   https://www.barrons.com/articles/antibiotics-could-clean-up-as-m-a-catalyst-1522685528 There' faxedreceipts 04/03/18 08:36:20 AM
#19   https://www.cnbc.com/2018/03/26/big-pharmas-scramble-to-invest-in-start-ups-to-f randychub 04/02/18 10:48:52 AM
#18   Excellent news with lousy market action...shrug! bUrRpPPP! 03/27/18 10:32:38 AM
#17   Roivant has to have a pretty good idea faxedreceipts 03/27/18 09:14:40 AM
#16   Roivant Sciences Enter into License Agreement to Develop faxedreceipts 03/27/18 09:13:59 AM
#15   NBRV filed a mixed shelf which is a bUrRpPPP! 03/17/18 04:45:20 PM
#14   $6.12 nice... bUrRpPPP! 03/08/18 06:12:37 PM
#13   Jumped in $5.17 for upcoming data run...eom bUrRpPPP! 02/10/18 06:09:36 PM
#12   Second phase 3 results to be reported in randychub 01/24/18 04:46:36 PM
#11   No one will ever accuse this company of hype randychub 01/10/18 09:57:52 AM
#10   did send ir email adobe 11/04/17 02:49:13 PM
#9   COULD not find on their site that they adobe 11/03/17 05:41:14 PM
#8   $10 plus next week; nymostwanted 09/22/17 08:45:21 PM
#7   https://seekingalpha.com/article/4108574-nabriva-looks-another-phase-3-seal-deal Inoviorulez 09/21/17 07:16:13 PM
#6   I am wanting to see above 14.10, just jet1968 09/20/17 04:13:37 PM
#5   Hoping to see a bigger bounce in the ilovestocks85 09/18/17 05:43:01 PM
#4   NBRV 9.49 bullish jet1968 09/18/17 02:03:13 PM
#3   Being Shorted to death after hitting $14s. runningwithscissors 09/18/17 10:17:23 AM
#2   Any Prediction of results due first half of J_Cali 08/29/17 10:34:57 PM
#1   NBRV bearish 7.38 stocktrademan 06/03/16 08:04:16 PM
PostSubject
© 2018 InvestorsHub.com, Inc.